Article Information
History
- December 7, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Mary K. Young1,
- Christine Kornmeier2,
- Rebecca M. Carpenter1,
- Nick R. Natale3,
- Jennifer M. Sasson1,
- Michael D. Solga4,
- Amy J. Mathers1,
- Melinda D. Poulter6,
- Xiao Qiang2 and
- William A. Petri Jr.1,5,6,^
- 1Department of Medicine, University of Virginia Health System, Charlottesville, VA, 22908, USA
- 2MilliporeSigma, St. Louis, MO, 63103, USA
- 3Department of Neuroscience, University of Virginia Health System, Charlottesville, VA, 22908, USA
- 4UVA Flow Cytometry Core, University of Virginia, Charlottesville, VA, 22908, USA
- 5Department of Microbiology, Immunology and Cancer Biology, University of Virginia Health System, Charlottesville, VA, 22908, USA
- 6Department of Pathology, University of Virginia Health System, Charlottesville, VA, 22908, USA
- ↵^Corresponding author; email: wap3g{at}virginia.edu
Posted December 07, 2020.
IgG Antibodies against SARS-CoV-2 Correlate with Days from Symptom Onset, Viral Load and IL-10
